GlaxoSmithKline's Avandia Is Back Under FDA Scrutiny Over Cardiac Risks Published: Jul 13, 2010 New York Times -- Related links New York Times This will open in a new window News Release This will open in a new window Fox News This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news